Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Shree Renuka Sugars, Sun Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Shree Renuka Sugars and Sun Pharmaceutical Industries.

    • Bata looks good, target Rs 525; Lupin can go up: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, Bata India looks good for target Rs 525 and feels that Lupin can go up and test Rs 1800.

    • Exit Glenmark Pharma at Rs 950: Vijay Chopra

      According to Vijay Chopra of enochventures.com, one may exit Glenmark Pharma at Rs 950.

    • Buy RCF, Can Fin Homes, NBCC, Bharat Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Rashtriya Chemicals and Fertilisers, Can Fin Homes, NBCC, Bharat Financial Inclusion and Bajaj Finance.

    • Axis Bank may test Rs 480, Sun Pharma Rs 666: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Axis Bank may test Rs 480 while Sun Pharma may hit Rs 666.

    • Buy, sell, hold: 12 stocks to watch out as earnings start

      JP Morgan stays neutral on TCS with target of Rs 2450 per share as company has shown weakness in revenue growth trajectory in recent quarters.

    • Anish Damania positive on Sun Pharmaceutical Industries

      Anish Damania of IDFC Securities is positive on Sun Pharmaceutical Industries.

    • Top buzzing stocks to trade on January 12

      Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.

    • Berger Paints can climb to Rs 228, like HCL Infosystems: Gaba

      Prakash Gaba of prakashgaba.com is of the view that Berger Paints can climb to Rs 228 and likes HCL Infosystems with target of Rs 62.

    • Hold Sun Pharmaceutical, says Rajat Bose

      According to Rajat Bose of rajatkbose.com, one may hold Sun Pharmaceutical Industries.

    • Buy, sell, hold: 9 pharma & media stocks that you may focus

      Citi upgrades Sun TV to buy and Zee Entertainment to neutral. It prefers Dish TV at current valuations, retaining buy call on the stock.

    • Buy Sun Pharmaceutical Industries on dips: Rajat Bose

      Rajat Bose of rajatkbose.com advises buying Sun Pharmaceutical Industries on dips.

    • Buy Sun Pharmaceuticals, Hindustan Construction: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can buy Sun Pharmaceuticals Industries and Hindustan Construction.

    • Buy RIL, Coromandel Intl, GSFC; sell Sun Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Reliance Industries, Coromandel International and GSFC and advises selling Divis Labs and Sun Pharma.

    • Buy, sell, hold: 6 stocks to watch out on 2016 last trading day

      Nomura is neutral on Lupin and Torrent. It has a buy rating on Dr Reddy‘s and Cadila. It says trailing three-month sales declined sequentially for Torrent, Sun Pharma and Glenmark. Torrent‘s sales were down on account of price erosion in gAbilify. Sun‘s T3M sales declined QoQ due to price erosion and market share loss in gGleevec.

    • Here are Deven Choksey's top trading ideas

      In an interview to CNBC-TV18 Deven Choksey, MD at KRChoksey Investment Managers shared his reading and outlook on the market.

    • Have a look at Tulsian's top bets in cement, pharma & NBFC space

      In an interview with CNBC-TV18, SP Tulsian of sptulsian.com gave his stock picks for the day and shared his market outlook.

    • Sell Canara Bank, buy Jamna Auto: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one can sell Canara Bank and buy Jamna Auto.

    • Buy, sell, hold: 4 stocks analysts recommend to watch out

      UBS has retained a buy call on Coromandel International with a target price of Rs 325 as it believes the stock is attractively valued at FY18 PE of 14x.

    • Here is why SP Tulsian is bullish on Hindustan Zinc

      SP Tulsian of sptulsian.com, talks about why he is bullish on Hindustan Zinc and other non-ferrous metal stocks. He also gives his views on the non-banking financial companies (NBFC).

    • Sell Sun Pharma, Bajaj Finance: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may sell Sun Pharmaceutical Industries and Bajaj Finance.

    • Stay invested in Sun Pharma, says Sharmila Joshi

      According to Sharmila Joshi of sharmilajoshi.com, one may hold Sun Pharmaceutical Industries.

    • Buy IRB Infra, CESC, Sun Pharma: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying IRB Infra, CESC and Sun Pharma.

    • Invest in Lupin, Tech Mahindra positional buy: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may invest in Lupin while Tech Mahindra is a positional buy.

    • Buy GSFC, Petronet; sell Sun Pharma, Bharti Infratel: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying GSFC and Petronet LNG and sell Sun Pharma, Bharti Infratel and JSW Steel.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347